S Monaco Selected Research

S Monaco Research Topics

Disease

9	Enterocolitis 05/2019 - 01/2012
6	Multiple Sclerosis 08/2020 - 11/2013
3	Food Hypersensitivity (Food Allergy) 05/2019 - 01/2017
2	Disease Progression 08/2020 - 11/2013
2	Milk Hypersensitivity (Milk Allergy) 07/2019 - 11/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 06/2000
2	Vomiting 04/2017 - 09/2000
2	Brain Injuries (Brain Injury) 09/2013 - 01/2008
2	Neoplasms (Cancer) 10/2006 - 11/2000
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 05/2005 - 11/2001
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2001 - 04/2001
1	COVID-19 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 09/2019
1	Asthma (Bronchial Asthma) 09/2019
1	Rhinitis 09/2019
1	Anaphylaxis (Anaphylactic Shock) 07/2019
1	Urticaria (Hives) 07/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Vasculitis (Vasculitides) 01/2018
1	Sudden Death 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Autoimmune Diseases of the Nervous System 01/2017
1	Cough 09/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2015
1	HIV Infections (HIV Infection) 05/2015
1	Opportunistic Infections (Opportunistic Infection) 05/2015
1	Atopic Dermatitis (Atopic Eczema) 03/2014
1	Persistent Vegetative State (Vegetative State) 09/2013
1	Exercise-Induced Allergies 05/2013
1	Neurofibroma 06/2010
1	Stroke (Strokes) 01/2008
1	Atherosclerosis 01/2008
1	Thrombosis (Thrombus) 01/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2008
1	Coronary Disease (Coronary Heart Disease) 01/2008
1	Inflammation (Inflammations) 01/2008
1	Atherosclerotic Plaque (Atheroma) 01/2008
1	Guillain-Barre Syndrome 12/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2006
1	Lymphoma (Lymphomas) 10/2006
1	Dementia (Dementias) 05/2005
1	Sporadic Creutzfeldt-Jakob Disease 11/2001
1	Inclusion Body Myositis 04/2001
1	Nonaka type Distal myopathy 04/2001
1	Atrophy 04/2001
1	Dermatomyositis (Dermatopolymyositis) 04/2001
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2001
1	Muscular Diseases (Myopathy) 04/2001
1	Muscular Atrophy (Muscle Atrophy) 04/2001
1	Ovarian Neoplasms (Ovarian Cancer) 11/2000
1	Intraoperative Complications 11/2000

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2012
8	Immunoglobulin E (IgE)IBA 07/2019 - 05/2013
5	Biomarkers (Surrogate Marker)IBA 08/2020 - 12/2006
3	tau Proteins (tau Protein)IBA 09/2013 - 05/2005
3	Protein Isoforms (Isoforms)IBA 05/2005 - 04/2001
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 01/2018
2	AntibodiesIBA 01/2017 - 06/2000
2	Fatty Acid Binding Protein 3IBA 09/2013 - 01/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2013 - 11/2000
2	Prion ProteinsIBA 11/2001 - 04/2001
1	mesoglycanIBA 01/2020
1	Vitamin D FDA LinkGeneric 09/2019
1	Glatiramer Acetate (Copaxone)FDA Link 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	AntigensIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Alemtuzumab (Campath)FDA Link 10/2017
1	IronIBA 06/2017
1	Ondansetron (Zofran)FDA LinkGeneric 04/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	dipropizine (dropropizine)IBA 09/2015
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 09/2015
1	Antitussive Agents (Antitussives)FDA Link 09/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2013
1	Calbindin 2IBA 06/2010
1	VimentinIBA 06/2010
1	Fatty Acid-Binding ProteinsIBA 01/2008
1	oxidized low density lipoproteinIBA 01/2008
1	LDL CholesterolIBA 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2008
1	14-3-3 Proteins (14-3-3 Protein)IBA 12/2006
1	Oncogene Proteins (Oncogene Protein)IBA 10/2006
1	Antipsychotic Agents (Antipsychotics)IBA 05/2005
1	Pharmaceutical PreparationsIBA 05/2005
1	Peptide Hydrolases (Proteases)FDA Link 11/2001
1	MetalsIBA 11/2001
1	Detergents (Detergent)IBA 04/2001
1	Endopeptidase K (Proteinase K)IBA 04/2001
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2000

Therapy/Procedure

3	Therapeutics 04/2017 - 01/2008
2	Analgesia 11/2000 - 09/2000
1	Aftercare (After-Treatment) 09/2015
1	Highly Active Antiretroviral Therapy (HAART) 05/2015
1	Denervation 04/2001